Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.31 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817103 | 0.96 | CNR2 (0.33) | CNR2CYSLTR2CYSLTR1POLBNR1I2 | |
| SCHEMBL557642 | 0.95 | NR1I2 (0.36) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL557339 | 0.93 | NR1I2 (0.38) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL198761 | 0.93 | NR1I2 (0.38) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL3218621 | 0.93 | NR1I2 (0.38) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL983291 | 0.93 | NR1I2 (0.38) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL982466 | 0.93 | NR1I2 (0.38) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL815962 | 0.93 | NR1I2 (0.36) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 | |
| SCHEMBL815762 | 0.93 | ESR1 (0.32) | — | |
| SCHEMBL980261 | 0.91 | NR1I2 (0.39) | CNR2CYSLTR2CYSLTR1NR1I2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103391942-B | Novel heterocyclic compound, method for producing intermediate thereof, and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2015-11-25 | — | — | CN | claimed |
| CN-103724215-A | Novel derivative of 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol and application of novel derivative | ZHENJIANG SHENGAN PHARMACEUTICAL CO LTD | 2014-04-16 | — | — | CN | claimed |
| US-8350256-B2 | Organic semiconductor compounds | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-01-08 | — | — | US | claimed |
| CN-101151331-B | Cyanine compound, optical filter and optical recording material | ADEKA CORP | 2012-10-31 | — | — | CN | claimed |
| CN-1911898-B | Triarylamine-based compound, method of preparing the same, and organic light emitting device using the triarylamine-based compound | SAMSUNG MOBILE DISPLAY CO LTD | 2012-05-02 | — | — | CN | claimed |
| US-20120012819-A1 | ORGANIC SEMICONDUCTOR COMPOUNDS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-01-19 | — | — | US | claimed |
| CN-102317243-A | Cleaning compositions and methods | HONEYWELL INT INC | 2012-01-11 | — | — | CN | claimed |
| CN-101031552-B | Optically active 4, 4-disubstituted oxazolidine derivative and process for producing the same | SANKYO CO | 2010-11-10 | — | — | CN | claimed |
| CN-100569827-C | The poly-indenofluorene that is used for the aryl replacement of organic electroluminescence device | MERCK PATENT GMBH (DE) | 2009-12-16 | — | — | CN | claimed |
| CN-101031552-A | Optically active 4, 4-disubstituted * oxazolidine derivatives and process for preparing same | SANKYO CO (JP) | 2007-09-05 | — | — | CN | claimed |
| CN-1293876-C | New application of 1,3-propylene glycol derivative | NOVARTIS AG (CH) | 2007-01-10 | — | — | CN | claimed |
| CN-1263825-C | Liquid crystal orientation agent, formation method of liquid crystal orientation membrane and liquid crystal display unit | JSR CORP (JP) | 2006-07-12 | — | — | CN | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| CN-1711301-A | Aryl-substituted polyindenofluorenes for use in organic electroluminiscent devices | COVION ORGANIC SEMICONDUCTORS (DE) | 2005-12-21 | — | — | CN | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| CN-1177258-C | Photo-thermo-sensitive imaging material | ��ʿ��Ƭ��ʽ���� | 2004-11-24 | — | — | CN | claimed |
| CN-1515253-A | New application of 1,3-propylene glycol derivative | ��˹��ŵ�� | 2004-07-28 | — | — | CN | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| CN-1062540-A | Organic phosphites suitable as stabilizers and polymer compositions containing them | HIMONT INC (US) | 1992-07-08 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | CNR2 3732/4885CYSLTR2 797/4885CYSLTR1 623/4885 |
| US-20120012819-A1 | ORGANIC SEMICONDUCTOR COMPOUNDS | TST, TPST2, BHMT2 | CNR2 3911/4885CYSLTR2 1097/4885CYSLTR1 2576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.